This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
FDA Drug information

Ivermectin

Read time: 1 mins
Marketing start date: 29 Apr 2024

Summary of product characteristics


Effective Time

20230607

Version

3

Spl Product Data Elements

ivermectin ivermectin IVERMECTIN IVERMECTIN CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) CETYL ALCOHOL CITRIC ACID MONOHYDRATE COCO DIETHANOLAMIDE DIMETHICONE DIMETHYL ISOSORBIDE EDETATE DISODIUM GLYCERIN ISOPROPYL PALMITATE METHYLPARABEN PROPYLPARABEN SODIUM HYDROXIDE SODIUM LAURYL SULFATE STEARYL ALCOHOL WATER white to pale yellow

Application Number

ANDA215210

Brand Name

Ivermectin

Generic Name

ivermectin

Product Ndc

70771-1728

Product Type

HUMAN PRESCRIPTION DRUG

Route

TOPICAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Ivermectin Cream, 1% 45 gm NDC 70771-1728-4 Rx only container label carton label

Spl Unclassified Section

SPL UNCLASSIFIED

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.